Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne ...

Researchers have discovered a potential therapeutic target in muscular disorders by identifying a previously unrecognized ...

A team at the University of Houston College of Pharmacy has discovered a possible therapeutic approach to repair injured ...

A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

Muscle atrophy is the loss of muscle mass. Low physical activity, nutritional deficiencies, genetic factors, and some medical conditions may contribute. Muscle atrophy due to inactivity can occur ...

A team has discovered a possible therapeutic approach to repair injured muscles either from aging or degenerative muscle disorders.

Researchers examine space station experiment samples brought back by the Shenzhou XVIII spacecraft at the Technology and ...